The IMCore of the UW Sensory Biology Center is pleased to announce the availability of an Illumina NextSeq 1000 sequencer. This equipment is purchased exclusively via an administrative supplement ...
Both FDA-regulated and CE-in vitro diagnostic (IVD) marked, the NextSeq 550Dx instrument enables ... environment and use the full range of Illumina sequencing methods for a wide range of applications.
Hosted on MSN27d
JP Morgan 2025: analysts remain doubtful of Illumina’s growthHowever, concerns were raised over a drop in placements of Illumina’s NextSeq systems last year. The company’s FY 2024 report noted that 2024 NextSeq shipments were down to 610 units ...
tumor tissue samples from cancer patients with solid malignant neoplasms using the Illumina® NextSeqâ„¢ 550Dx Instrument. The test can be used to detect single nucleotide variants, multi-nucleotide ...
CTCs and ctDNA were then analysed using Illumina’s customised 79 gene lung cancer panel with NGS completed on the Illumina NextSeq 2000 platform. In the patients that had not received any treatment ...
CTCs and ctDNA were then analysed using Illumina's customised 79 gene lung cancer panel with NGS completed on the Illumina NextSeq 2000 platform. In the patients that had not received any treatment ...
CTCs and ctDNA were then analysed using Illumina’s customised 79 gene lung cancer panel with NGS completed on the Illumina NextSeq 2000 platform. In the patients that had not received any treatment ...
GUILDFORD, SURREY / ACCESS Newswire / January 29, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results